Nancy Ryan Gray

Insider Reports History

Entity
Individual
Location
C/O Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard, Ste 110, San Diego, CA
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Nancy Ryan Gray
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Ryan Gray:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Director Common Stock 6.89K $597K $86.65 Jun 14, 2024 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 5.44K Jun 14, 2024 Direct

Insider Reports Filed by Nancy Ryan Gray

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LGND LIGAND PHARMACEUTICALS INC Jun 14, 2024 2 $0 4 Jun 18, 2024 Director
LGND LIGAND PHARMACEUTICALS INC May 9, 2024 1 -$77.7K 4 May 17, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Jun 9, 2023 2 $0 4 Jun 13, 2023 Director
LGND LIGAND PHARMACEUTICALS INC Dec 22, 2022 1 $0 4 Dec 27, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Jun 10, 2022 2 $0 4 Jun 13, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Jun 4, 2021 2 $0 4 Jun 7, 2021 Director